Phytoestrogens as neuroprotectants

Drugs of Today

Volumn 45, Issue 8, 2009, Pages 609-627

  Schreihofer, Derek A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CHRYSIN; COUMESTROL; CURCUMIN; DAIDZEIN; ENTEROLACTONE; EPICATECHIN; EPIGALLOCATECHIN GALLATE; EQUOL; ESTRADIOL; FISETIN; FLAVONOL; GENISTEIN; ISOFLAVONE; KAEMPFEROL; NARINGENIN; PHYTOESTROGEN; PUERARIN; QUERCETIN; RESVERATROL; NEUROPROTECTIVE AGENT;

AGING; ALZHEIMER DISEASE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG STRUCTURE; DRUG USE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MENOPAUSAL SYNDROME; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE MODEL; NEURODEGENERATIVE DISEASES;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; HUMANS; MOLECULAR STRUCTURE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PHYTOESTROGENS;

EID: 76149117812     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2009.45.8.1395520     Document Type: Review

References (218)

1. Rossouw, J.E., Anderson, G.L., Prentice, R.L. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002, 288(3): 321-33.
2. Anderson, G.L., Limacher, M., Assaf, A.R. et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004, 291(14): 1701-12.
3. Brass, L.M. Hormone replacement therapy and stroke: Clinical trials review. Stroke 2004, 35 (11, Suppl. 1): 2644-7.
4. Kelly, J.P., Kaufman, D.W., Rosenberg, L. et al. Use of postmenopausal hormone therapy since the Women's Health Initiative findings. Pharmacoepidemiol Drug Saf 2005, 14(12): 837-42.
5. Newton, K.M., Buist, D.S., Keenan, N.L. et al. Use of alternative therapies for menopause symptoms: Results of a population-based survey. Obstet Gynecol 2002, 100(1): 18-25.
6. Wathen, C.N. Alternatives to hormone replacement therapy: A multi-method study of women's experiences. Complement Ther Med 2006, 14(3): 185-92.
7. Kupferer, E.M., Dormire, S.L., Becker, H. Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy. J Obstet Gynecol Neonatal Nurs 2009, 38(1): 50-9.
8. Pozzi, S., Benedusi, V., Maggi, A. et al. Estrogen action in neuroprotection and brain inflammation. Ann N Y Acad Sci 2006, 1089: 302-23.
9. Brann, D.W., Dhandapani, K., Wakade, C. et al. Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications. Steroids 2007, 72(5): 381-405.
10. Simpkins, J.W., Singh, M. More than a decade of estrogen neuroprotection. Alzheimers Dement 2008, 4 (1, Suppl. 1): S131-6.
11. Zand, R.S., Jenkins, D.J., Diamandis, E.P. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 2000, 62(1): 35-49.
12. Turner, J.Y., Agatonovic-Kustrin, S., Glass, B.D. Molecular aspects of phytoestrogen selective binding at estrogen receptors. J Pharm Sci 2007, 96(8): 1879-85.
13. Whitten, P.L., Patisaul, H.B. Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect 2001, 109 (Suppl. 1): 5-20.
14. Mandel, S.A., Avramovich-Tirosh, Y., Reznichenko, L. et al. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 2005, 14(1-2): 46-60.
15. Kuruto-Niwa, R., Inoue, S., Ogawa, S. et al. Effects of tea catechins on the ERE-regulated estrogenic activity. J Agric Food Chem 2000, 48(12): 6355-61.
16. Goodin, M.G., Fertuck, K.C., Zacharewski, T.R. et al. Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicol Sci 2002, 69(2): 354-61.
17. Ramsey, T.L., Risinger, K.E., Jernigan, S.C et al. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner. Endocrinology 2004, 145(1): 149-60.
18. Milligan, S.R., Balasubramanian, A.V., Kalita, J.C. Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. Environ Health Perspect 1998, 106(1): 23-6.
19. Kostelac, D., Rechkemmer, G., Briviba, K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 2003, 51(26): 7632-5.
20. Harris, D.M., Besselink, E., Henning, S.M. et al. Phytoestrogens induce differential estrogen receptor alpha- or β-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood) 2005, 230(8): 558-68.
21. Smith, C.L., O'Malley, B.W. Coregulator function: A key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004, 25(1): 45-71.
22. Kuiper, G.G.J.M., Lemmen, J.G., Carlsson, B. et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998, 139(10): 4252-63.
23. Hall, J.M., Korach, K.S. Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in target promoter regulation by xenoestrogens. J Biol Chem 2002, 277(46): 44455-61.
24. Mueller, S.O., Simon, S., Chae, K. et al. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 2004, 80(1): 14-25.
25. Hurn, P.D., Macrae, I.M. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 2000, 20(4): 631-52.
26. Hurn, P.D., Brass, L.M. Estrogen and stroke: A balanced analysis. Stroke 2003, 34(2): 338-41.
27. McCullough, L.D., Hurn, P.D. Estrogen and ischemic neuroprotection: An integrated view. Trends Endocrinol Metab 2003, 14(5): 228-35.
28. Merchenthaler, I., Dellovade, T.L., Shughrue, P.J. Neuroprotection by estrogen in animal models of global and focal ischemia. Ann N Y Acad Sci 2003, 1007: 89-100.
29. Gibson, C.L., Gray, L.J., Murphy, S.P. et al. Estrogens and experimental ischemic stroke: A systematic review. J Cereb Blood Flow Metab 2006, 26(9): 1103-13.
30. Emerson, C.S., Headrick, J.P., Vink, R. Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females. Brain Res 1993, 608(1): 95-100.
31. Roof, R.L., Hall, E.D. Gender differences in acute CNS trauma and stroke: Neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000, 17(5): 367-88.
32. Bramlett, H.M., Dietrich, W.D. Neuropathology protection after traumatic brain injury in intact female rats versus males or ovariectomized females. J Neurotrauma 2001, 18(9): 891-900.
33. Aguado-Llera, D., Arilla-Ferreiro, E., Chowen, J.A. et al. 17beta-Estradiol protects depletion of rat temporal cortex somatostatinergic system by beta-amyloid. Neurobiol Aging 2007, 28(9): 1396-409.
34. Hruska, Z., Dohanich, G.P. The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid. Horm Behav 2007, 52(3): 297-306.
35. Callier, S., Morissette, M., Grandbois, M. et al. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57BI/6 mice. Synapse 2001, 41(2): 131-8.
36. Gelinas, S., Martinoli, M.G. Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells. J Neurosci Res 2002, 70(1): 90-6.
37. Morissette, M., Jourdain, S., Al Sweidi, S. et al. Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity. Neuropharmacology 2007, 52(7): 1509-20.
38. Morissette, M., Al Sweidi, S., Callier, S. et al. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 2008, 290(1-2): 60-9.
39. Reibel, S., Andre, V., Chassagnon, S. et al. Neuroprotective effects of chronic estradiol benzoate treatment on hippocam pal cell loss induced by status epilepticus in the female rat. Neurosci Lett 2000, 281(2-3): 79-82.
40. Azcoitia, I., Sierra, A., Veiga, S. et al. Brain aromatase is neuroprotective. J Neurobiol 2001, 47(4): 318-29.
41. Mendelowitsch, A., Ritz, M.F., Ros, J. et al. 17beta-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: A new neuroprotective pathway. Brain Res 2001, 901(1-2): 230-6.
42. Rosario, E.R., Ramsden, M., Pike, C.J. Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res 2006, 1099(1): 206-10.
43. Corasaniti, M.T., Amantea, D., Russo, R. et al. 17beta-Estradlol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurotoxicology 2005, 26(5): 893-903.
44. Dubal, D.B., Zhu, H., Yu, J. et al. Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 2000, 98(4): 1952-7.
45. Sampei, K., Goto, S., Alkayed, N.J. et al. Stroke in estrogen receptor-alpha-deficient mice. Stroke 2000, 31(3): 738-43; discussion 744.
46. Carswell, H.V., Macrae, I.M., Gallagher, L. et al. Neuroprotection by a selective estrogen receptor {beta} agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol 2004, 287(4): H1501-H4.
47. Farr, T.D., Carswell, H.V., Gsell, W. et al. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res 2007, 1185: 275-82.
48. Suzuki, S., Gerhold, L.M., Bottner, M. et al. Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta. J Comp Neurol 2007, 500(6): 1064-75.
49. D'Astous, M., Morissette, M., Di Paolo, T. Effect of estrogen receptor agonists treatment in MPTP mice: Evidence of neuroprotection by an ER alpha agonist. Neuropharmacology 2004, 47(8): 1180-8.
50. Meltser, I., Tahera, Y., Simpson, E. et al. Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest 2008, 118(4): 1563-70.
51. Amantea, D., Russo, R., Bagetta, G. et al. From clinical evidence to molecular mechanisms undedying neuroprotection afforded by estrogens. Pharmacol Res 2005, 52(2): 119-32.
52. Simpkins, J.W., Dykens, J.A. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev 2008, 57(2): 421-30.
53. Manthey, D., Behl, C. From structural biochemistry to expression profiling: Neuroprotective activities of estrogen. Neuroscience 2006, 138(3): 845-50.
54. Prokai, L., Simpkins, J.W. Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Pharmacol Ther 2007, 114(1): 1-12.
55. Raz L., Khan M.M., Mahesh V.B. et al. Rapid estrogen signaling in the brain. Neurosignals 2008, 16(2-3): 140-53.
56. Zhao, L., Chen, Q., Diaz Brinton, R. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp Biol Med (Maywood) 2002, 227(7): 509-19.
57. Schreihofer, D.A., Redmond, L. Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience 2009, 158(2): 602-9.
58. Ho, K.P., Li, L., Zhao, L. et al. Genistein protects primary cortical neurons from iron-induced lipid peroxidation. Mol Cell Biochem 2003, 247(1-2): 219-22.
59. Linford, N.J., Dorsa, D.M. 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 2002, 67(13-14): 1029-40.
60. Yu, H.L., Li, L., Zhang, X.H. et al. Neuroprotective effects of genistein and folic acid on apoptosis of rat cultured cortical neurons induced by beta-amyloid 31-35. Br J Nutr 2009, 102(5): 655-62.
61. Mercer, L.D., Kelly, B.L., Horne, M.K. et al. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: Investigations in primary rat mesencephalic cultures. Biochem Pharmacol 2005, 69(2): 339-45.
62. Wang, C.N., Chi, C.W., Lin, Y.L. et al. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem 2001, 276(7): 5287-95.
63. Alvira, D., Yeste-Velasco, M., Folch, J. et al. Comparative analysis of the effects of resveratrol in two apoptotic models: Inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 2007, 147(3): 746-56.
64. Chong, Z.Z., Maiese, K. Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. Curr Neurovasc Res 2008, 5(3): 159-70.
65. Zamin, L.L., Dillenburg-Pilla, P., Argenta-Comiran, R. et al. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: Involvement of PI3-K pathway. Neurobiol Dis 2006, 24(1): 170-82.
66. Zhang, H., Schools, G.P., Lei, T. et al. Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation. Exp Neurol 2008, 212(1): 44-52.
67. Ha, H.J., Kwon, Y.S., Park, S.M. et al. Quercetin attenuates oxygen-glucose deprivation- and excitotoxin-induced neurotoxicity in primary cortical cell cultures. Biol Pharm Bull 2003, 26(4): 544-6.
68. Silva, B., Oliveira, P.J., Dias, A. et al. Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotec tive against excitotoxic insults. Neurotox Res 2008, 13(3-4): 265-79.
69. Xu, X., Zheng, X. Potential involvement of calcium and nitric oxide in protective effects of puerarin on oxygen-glucose deprivation in cultured hippocampal neurons. J Ethnopharmacol 2007, 113(3): 421-6.
70. Sloley, B.D., Urichuk, L.J., Morley, P. et al. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol 2000, 52(4): 451-9.
71. Yazawa, K., Kihara, T., Shen, H. et al. Distinct mechanisms underlie distinct polyphenol-induced neuroprotection. FEBS Lett 2006, 580(28-29): 6623-8.
72. Schroeter, H., Spencer, J.P., Rice-Evans, C. et al. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 2001, 358(Pt. 3): 547-57.
73. Antonio, A.M., Druse, M.J. Antioxidants prevent ethanol-associated apoptosis in fetal rhombencephalic neurons. Brain Res 2008, 1204: 16-23.
74. Levites, Y., Amit, T., Mandel, S. et al. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3- gallote. FASEB J 2003, 17(8): 952-4.
75. Rossouw, J.E., Prentice, R.L., Manson, J.E. et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297(13): 1465-77.
76. Schreihofer, D.A., Do, K.D., Schreihofer, A.M. High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats. Am J Physiol Regul Integr Comp Physiol 2005, 289(1): R103-8.
77. Lovekamp-Swan, T., Glendenning, M., Schreihofer, D.A. A high soy diet reduces programmed cell death and enhances bcl-x(L) expression in experimental stroke. Neuroscience 2007, 148(3): 644-52.
78. Burguete, M.C., Torregrosa, G., Perez-Asensio, F.J. et al. Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats. Eur J Neurosci 2006, 23(3): 703-10.
79. Pan, Y., Anthony, M., Clarkson, T.B. Evidence for up-regulation of brain-derived neurotrophic factor mRNA by soy phytoestrogens in the frontal cortex of retired breeder female rats. Neurosci Lett 1999, 261(1-2): 17-20.
80. Bu, L., Lephart, E.D. Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neurosci Lett 2005, 385(2): 153-7.
81. Lovekamp-Swan, T., Glendenning, M.L., Schreihofer, D.A. A high soy diet enhances neurotropin receptor and Bcl-XL gene expression in the brains of ovariectomized female rats. Brain Res 2007, 1159: 54-66.
82. Trieu, V.N., Uckun, F.M. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun 1999, 258(3): 685-8.
83. Kindy, M.S. Inhibition of tyrosine phosphorylation prevents delayed neuronal death following cerebral ischemia. J Cereb Blood Flow Metab 1993, 13(3): 372-7.
84. Liang, H.W., Qiu, S.F., Shen, J. et al. Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci Lett 2008, 438(1): 116-20.
85. Linford, N.J., Yang, Y., Cook, D.G. et al. Neuronal apoptosis resulting from high doses of the isoflavone genistein: Role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 2001, 299(1): 67-75.
86. Huang, S.S., Tsai, M.C., Chih, C.L. et al. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 2001, 69(9): 1057-65.
87. Yousuf, S., Atif, F., Ahmad, M. et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 2009, 1250: 242-53.
88. Sinha, K., Chaudhary, G., Gupta, Y.K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002, 71(6): 655-65.
89. Andrabi, S.A., Spina, M.G., Lorenz, P. et al. Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Res 2004, 1017(1-2): 98-107.
90. Tsai, S.K., Hung, L.M., Fu, Y.T. et al. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 2007, 46(2): 346-53.
91. Dong, W., Li, N., Gao, D. et al. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 2008, 48(3): 709-14.
92. Della-Morte, D., Dave, K.R., DeFazio, R.A. et al. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009, 159(3): 993-1002.
93. Wang, Q., Xu, J., Rottinghaus, G.E. et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 2002, 958(2): 439-47.
94. Dajas, F., Rivera-Megret, F., Blasina, F. et al. Neuroprotection by flavonoids. Braz J Med Biol Res 2003, 36(12): 1613-20.
95. Sarkar, S., Das, N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech Ageing Dev 2006, 127(4): 391-7.
96. Cho, J.Y., Kim, I.S., Jang, Y.H. et al. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci Lett 2006, 404(3): 330-5.
97. Rivera, F., Costa, G., Abin, A. et al. Reduction of ischemic brain damage and increase of glutathione by a liposomal preparation of quercetin in permanent focal ischemia in rats. Neurotox Res 2008, 13(2): 105-14.
98. Xu, X., Zhang, S., Zhang, L. et al. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med 2005, 71(7): 585-91.
99. Pan, H.P., Li, G. Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia-reperfusion injury. Yakugaku Zasshi 2008, 128(11): 1689-98.
100. Chang, Y., Hsieh, C.Y., Peng, Z.A. et al. Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J Biomed Sci 2009, 16(1): 9.
101. Gao, L., Ji, X., Song, J. et al. Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. Neurol Res 2009, 31(4): 402-6.
102. Wu, H.Q., Guo, H.N., Wang, H.Q. et al. Protective effects and mechanism of puerarin on learning-memory disorder after global cerebral ischemia-reperfusion injury in rats. Chin J Integr Med 2009, 15(1): 54-9.
103. Lopez-Sanchez, C., Martin-Romero, F.J., Sun, F. et al. Blood micromolar concentrations of kaempferol afford protection against ischemia/reperfusion-induced damage in rat brain. Brain Res 2007, 1182: 123-37.
104. Ha, S.K., Lee, P., Park, J.A. et al. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem Int 2008, 52(4-5): 878-86.
105. Lee, S., Suh, S., Kim, S. Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 2000, 287(3): 191-4.
106. Kiziltepe, U., Turan, N.N., Han, U. et al. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 2004, 40(1): 138-45.
107. Kaplan, S., Bisleri, G., Morgan, J.A. et al. Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg 2005, 80(6): 2242-9.
108. Sang, H.F., Mei, Q.B., Xu, L.X. et al. Effect of puerarin on neural function and histopathological damages after transient spinal cord ischemia in rabbits. Chin J Traumatol 2004, 7(3): 143-7.
109. Ma, W.W., Xiang, L., Yu, H.L. et al. Neuroprotection of soyabean isoflavone co-administration with folic acid against beta-amyloid 1-40-induced neurotoxicity in rats. Br J Nutr 2009, 102(4): 502-5.
110. Hsieh, H.M., Wu, W.M., Hu, M.L. Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer's disease in C57BL/6J mice treated with D-galactose. Food Chem Toxicol 2009, 47(3): 625-32.
111. Sarkaki, A., Amani, R., Badavi, M. et al. Pre-treatment effect of different doses of soy isoflavones on spatial learning and memory in an ovariectomized animal model of Alzheimer's disease. Pak J Biol Sci 2008, 11(8): 1114-9.
112. Wang, J., Ho, L., Zhao, Z. et al. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 2006, 20(13): 2313-20.
113. Karuppagounder, S.S., Pinto, J.T., Xu, H. et al. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int 2009, 54(2): 111-8.
114. Kim, D., Nguyen, M.D., Dobbin, M.M. et al. SIRTI deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007, 26(13): 3169-79.
115. Haque, A.M., Hashimoto, M., Katakura, M., et al. Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J Nutr Biochem 2008, 19(9): 619-26.
116. Kyuhou, S. Preventive effects of genistein on motor dysfunction following 6-hydroxydopamine injection in ovariectomized rats. Neurosci Lett 2008, 448(1): 10-4.
117. Baluchnejadmojarad, T., Roghani, M., Nadoushan, M.R. et al. Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model. Phytother Res 2009, 23(1): 132-5.
118. Zbarsky, V., Datla, K.P., Parkar, S. et al. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005, 39(10): 1119-25.
119. Liu, L.X., Chen, W.F., Xie, J.X. et al. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Neurosci Res 2008, 60(2): 156-61.
120. Blanchet, J., Longpre, F., Bureau, G. et al. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(5): 1243-50.
121. Wang, X., Chen, S., Ma, G. et al. Genistein protects dopaminergic neurons by inhibiting microglial activation. Neuroreport 2005, 16(3): 267-70.
122. Okawara, M., Katsuki, H., Kurimoto, E. et al. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol 2007, 73(4): 550-60.
123. Chao, J., Yu, M.S., Ho, Y.S. et al. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic Biol Med 2008, 45(7): 1019-26.
124. De Paula, M.L., Rodrigues, D.H., Teixeira, H.C. et al. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis. Int Immunopharmacol 2008, 8(9): 1291-7.
125. Singh, N.P., Hegde, V.L., Hofseth, L.J. et al. Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 2007, 72(6): 1508-21.
126. Muthian, G., Bright, J.J. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J Clin Immunol 2004, 24(5): 542-52.
127. Verbeek, R., van Tol, E.A., van Noort, J.M. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem Pharmacol 2005, 70(2): 220-8.
128. Sonmez, U., Sonmez, A., Erbil, G. et al. Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett 2007, 420(2): 133-7.
129. Ates, O., Cayli, S., Altinoz, E. et al. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 2007, 294(1-2): 137-44.
130. Schultke, E., Kamencic, H., Zhao, M. et al. Neuroprotection following fluid percussion brain trauma: a pilot study using quercetin. J Neurotrauma 2005, 22(12): 1475-84.
131. Yang, Y.B., Piao, Y.J. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol Sin 2003, 24(7): 703-10.
132. Schultke, E., Kendall, E., Kamencic, H. et al. Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 2003, 20(6): 583-91.
133. Lee, Y.B., Lee, H.J., Won, M.H. et al. Soy isoflavones improve spatial delayed matching-to-place performance and reduce cholinergic neuron loss in elderly male rats. J Nutr 2004, 134(7): 1827-31.
134. Pan, Y. Anthony, M., Watson, S. et al. Soy phytoestrogens improve radial arm maze performance in ovariectomized retired breeder rats and do not attenuate benefits of 17beta-estradiol treatment. Menopause 2000, 7(4): 230-5.
135. Perez-Martin, M., Salazar, V., Castillo, C. et al. Estradiol and soy extract increase the production of new cells in the dentate gyrus of old rats. Exp Gerontol 2005, 40(5): 450-3.
136. Lund, T.D., West, T.W., Tian, L.Y. et al. Visual spatial memory is enhanced in female rots (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci 2001, 2(1): 20.
137. Monteiro, S.C., de Mattos, C.B., Ben, J. et al. Ovariectomy impairs spatial memory, prevention and reversal by a soy isoflavone diet. Metab Brain Dis 2008, 23(3): 243-53.
138. Luine, V., Attalla, S., Mohan, G. et al. Dietary phytoestrogens enhance spatial memory and spine density in the hippocam pus and prefrontal cortex of ovariectomized rats. Brain Res 2006, 1126(1): 183-7.
139. Shi, C., Xu, J. Increased vulnerability of brain to estrogen withdrawal-induced mitochondrial dysfunction with aging. J Bioenerg Biomembr 2008, 40(6): 625-30.
140. Haque, A.M., Hashimoto, M., Katakura, M. et al. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006, 136(4): 1043-7.
141. Pu, F., Mishima, K., Irie, K. et al. Neuroprotective effects of quercetin and rutin on spatial memory Impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 2007, 104(4): 329-34.
142. Kumar, A., Naidu, P.S., Seghal, N. et al. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 2007, 79(1): 17-26.
143. Kritz-Silverstein, D., Von Muhlen, D., Barrett-Connor, E. et al. Isoflavones and cognitive function in older women: The SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause 2003, 10(3): 196-202.
144. Casini, M.L., Marelli, G., Papaleo, E. et al. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: A randomized, double-blind, crossover, placebo-controlled study. Fertil Steril 2006, 85(4): 972-8.
145. File, S.E., Hartley, D.E., Elsabagh, S. et al. Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause 2005, 12(2): 193-201.
146. Duffy, R., Wiseman, H., File, S.E. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav 2003, 75(3): 721-9.
147. Islam, F., Sparkes, C., Roodenrys, S. et al. Short-term changes in endogenous estrogen levels and consumption of soy isoflavones affect working and verbal memory in young adult females. Nutr Neurosci 2008, 11(6): 251-62.
148. Celec, P., Ostatnikova, D., Caganova, M. et al. Endocrine and cognitive effects of short-time soybean consumption in women. Gynecol Obstet Invest 2005, 59(2): 62-6.
149. Ostatnikova, D., Celec, P., Hodosy, J. et al. Short-term soybean intake and its effect on steroid sex hormones and cognitive abilities. Fertil Steril 2007, 88(6): 1632-6.
150. Gleason, C.E., Carlsson, C.M., Barnet, J.H. et al. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing 2009, 38(1): 86-93.
151. Ho, S.C., Chan, A.S., Ho, Y.P. et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: A double-blind, randomized, controlled trial. Menopause 2007, 14(3, Pt. 1): 489-99.
152. Fournier, L.R., Ryan Borchers, T.A., Robison, L.M. et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging 2007, 11(2): 155-64.
153. Kreijkamp-Kaspers, S., Kok, L., Grobbee, D.E. et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: A randomized controlled trial. Jama 2004, 292(1): 65-74.
154. Huang, M.H., Luetters, C., Buckwalter, G.J. et al. Dietary genistein intake and cognitive performance in a multiethnic cohort of midlife women. Menopause 2006, 13(4): 621-30.
155. White, L.R., Petrovitch, H., Ross, C.W. et al. Brain aging and midlife tofu consumption. J Am Coll Nutr 2000, 19(2): 242-55.
156. Franco, O.H., Burger, H., Lebrun, C.E. et al. Higher dietary intake of lignons is associated with better cognitive performance in postmenopausal women. J Nutr 2005, 135(5): 1190-5.
157. Woo, J., Lau, E., Ho, S.C. et al. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 2003, 10(4): 352-61.
158. Mense, S.M., Hei, T.K., Ganju, R.K. et al. Phytoestrogens and breast cancer prevention: Possible mechanisms of action. Environ Health Perspect 2008, 116(4): 426-33.
159. Jian, L. Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 2009, 53(2): 217-26.
160. Dang, Z.C., Lowik, C. Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol Metab 2005, 16(5): 207-13.
161. Siow, R.C., Li, F.Y., Rowlands, D.J. et al. Cardiovascular targets for estrogens and phytoestrogens: Transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med 2007, 42(7): 909-25.
162. Lephart, E.D., Porter, J.P., Hedges, D.W. et al. Phytoestrogens: Implications in neurovascular research. Curr Neurovasc Res 2004, 1(5): 455-64.
163. Cassidy, A., de Pascual Teresa, S., Rimbach, G. Molecular mechanisms by which dietary isoflavones potentially prevent atherosclerosis. Expert Rev Mol Med 2003, 5(24): 1-15.
164. Li, Q., Zhao, H.F., Zhang, Z.F. et al. Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade. Neuroscience 2009, 159(4): 1208-15.
165. Pan, Y., Anthony, M., Clarkson, T.B. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med 1999, 221(2): 118-25.
166. Sonee, M., Sum, T., Wang, C. et al. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology 2004, 25(5): 885-91.
167. Lee, M.K., Kang, S.J., Poncz, M. et al. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med 2007, 39(3): 376-84.
168. Koh, S.H., Kim, S.H., Kwon, H. et al. Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cells. Neurotoxicology 2004, 25(5): 793-802.
169. Valles, S.L., Borras, C., Gambini, J. et al. Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38. Aging Cell 2008, 7(1): 112-8.
170. Lu, K.T., Ko, M.C., Chen, B.Y. et al. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 2008, 56(16): 6910-3.
171. Bournival, J., Quessy, P., Martinoli, M.G. Protective effects of resveratrol and quercetin against MPP(+)-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol 2009, Epub ahead of print.
172. Ansari, M.A., Abdul, H.M., Joshi, G. et al. Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. J Nutr Biochem 2009, 20(4): 269-75.
173. Heo, H.J., Lee, C.Y. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J Agric Food Chem 2004, 52(25): 7514-7.
174. Kajta, M., Domin, H., Grynkiewicz, G. et al. Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: An involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase
175. Zeng, H., Chen, Q., Zhao, B. Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 2004, 36(2): 180-8.
176. Bang, O.Y., Hong, H.S., Kim, D.H. et al. Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis 2004, 16(1): 21-8.
177. Dang, Z.C., Audinot, V., Papapoulos, S.E. et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003, 278(2): 962-7.
178. Bordet, R., Ouk, T., Petrault, O. et al. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 2006, 34(Pt. 6): 1341-6.
179. Han, Y.S., Bastianetto, S., Dumont, Y. et al. Specific plasma membrane binding sites for polyphenols, including resvera trol, in the rat brain. J Pharmacol Exp Ther 2006, 318(1): 238-45.
180. Lee, Y.W., Lee, W.H. Protective effects of genistein on proinflammatory pathways in human brain microvascular endothelial cells. J Nutr Biochem 2008, 19(12): 819-25.
181. Lu, H., Shi, J.X., Zhang, D.M. et al. Genistein, a soybean isoflavone, reduces the production of pro-inflammatory and adhesion molecules induced by hemolysate in brain microvascular endothelial cells. Acta Neurol Belg 2009, 109(1): 32-7.
182. Sharma, V., Mishra, M., Ghosh, S. et al. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection. Brain Res Bull 2007, 73(1-3): 55-63.
183. Gao, H., Liang, M., Bergdahl, A. et al. Estrogen attenuates vascular expression of inflammation associated genes and adhesion of monocytes to endothelial cells. Inflamm Res 2006, 55(8): 349-53.
184. Wuttke, W., Jarry, H., Seidlova-Wuttke, D. Isoflavones - Safe food additives or dangerous drugs? Ageing Res Rev 2007, 6(2): 150-88.
185. Xiao, C.W. Health effects of soy protein and isoflavones in humans. J Nutr 2008, 138(6): 1244S-9S.
186. Setchell, K.D. Soy isoflavones - Benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001, 20(5, Suppl.): 354S-62S; discussion 81S-83S.
187. Munro, I.C., Harwood, M., Hlywka, J.J. et al. Soy isoflavones: A safety review. Nutr Rev 2003, 61(1): 1-33.
188. McClain, R.M., Wolz, E., Davidovich, A. et al. Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 2005, 44(1): 56-80.
189. Jefferson, W.N., Padilla-Banks, E., Newbold, R.R. Disruption of the developing female reproductive system by phytoestrogens: Genistein as an example. Mol Nutr Food Res 2007, 51(7): 832-44.
190. Atteritano, M., Marini, H., Minutoli, L. et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2007, 92(8): 3068-75.
191. Atteritano, M., Pernice, F., Mazzaferro, S. et al. Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 Year randomized, placebo-controlled study. Eur J Pharmacol 2008, 589(1-3): 22-6.
192. D'Anna, R., Cannata, M.L., Marini, H. et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: A 2-year randomized, double-blind, placebo-controlled study. Menopause 2009, 16(2): 301-6.
193. Lamartiniere, C.A., Wang, J., Smith-Johnson, M. et al. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci 2002, 65(2): 228-38.
194. Williams, L.D., Burdock, C.A., Edwards, J.A. et al. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem Toxicol 2009, 47(9): 2170-82.
195. Almeida, L., Vaz-da-Silva, M., Falcao, A. et al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 2009, 53(Suppl. 1): S7-15.
196. Harwood, M., Danielewska-Nikiel, B., Borzelleca, J.F. et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007, 45(11): 2179-205.
197. Ogura, R., Ikeda, N., Yuki, K. et al. Genotoxicity studies on green tea catechin. Food Chem Toxicol 2008, 46(6): 2190-200.
198. Yoneda, T., Shoji, K., Takase, H. et al. Effectiveness and safety of 1-year ad libitum consumption of a high-catechin beverage under nutritional guidance. Metab Syndr Relat Disord 2009, 7(4): 349-56.
199. Jin, Y., Wu, H., Cohen, E.M. et al. Genistein and daidzein induce neurotoxicity at high concentrations in primary rat neuronal cultures. J Biomed Sci 2007, 14(2): 275-84.
200. Choi, E.J., Lee, B.H. Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sci 2004, 75(4): 499-509.
201. Choi, E.J. The prooxidant, rather than antioxidant, acts of daidzein in vivo and in vitro: daidzein suppresses glutathione metabolism. Eur J Pharmacol 2006, 542(1-3): 162-9.
202. Sharma, V., Joseph, C., Ghosh, S. et al. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 2007, 6(9): 2544-53.
203. Lo, F.H., Mak, N.K., Leung, K.N. Studies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cells. Biomed Pharmacother 2007, 61(9): 591-5.
204. Brown, A., Jolly, P., Wei, H. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis 1998, 19(6): 991-7.
205. Lin, H.Y., Tang, H.Y., Keating, T. et al. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: Both actions are integrin and ERK mediated. Carcinogenesis 2008, 29(1): 62-9.
206. Yokoyama, S., Hirano, H., Wakimaru, N. et al. Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro. Neuro Oncol 2001, 3(1): 22-8.
207. Sharma, V., McNeill, J.H. To scale or not to scale: The principles of dose extrapolation. Br J Pharmacol 2009, 157(6): 907-21.
208. Setchell, K.D., Brown, N.M., Desai, P.B. et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003, 133(4): 1027-35.
209. Cassidy, A., Brown, J.E., Hawdon, A. et al. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 2006, 136(1): 45-51.
210. Lephart, E.D., Adlercreutz, H., Lund, T.D. Dietary soy phytoestrogen effects on brain structure and aromatase in Long-Evans rats. Neuroreport 2001, 12(16): 3451-5.
211. Juan, M.E., Maijo, M., Planas, J.M. Quantification of transresveratrol and its metabolites in rat plasma and tissues by HPLC. J Pharm Biomed Anal 2009, 51(2): 391-8.
212. de Boer, V.C., Dihal, A.A., van der Woude, H. et al. Tissue distribution of quercetin in rats and pigs. J Nutr 2005, 135(7): 1718-25.
213. Lin, L.C., Wang, M.N., Tseng, T.Y. et al. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely mov ing rats and its brain regional distribution. J Agric Food Chem 2007, 55(4): 1517-24.
214. Mattson, M.P., Cheng, A. Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 2006, 29(11): 632-9.
215. Vina, J., Sastre, J., Pallardo, F.V. et al. Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem 2008, 389(3): 273-7.
216. Kang, S.S., Lee, J.Y., Choi, Y.K. et al. Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblastoma cells. Bioorg Med Chem Lett 2004, 14(9): 2261-4.
217. Wu, Z., Xu, Q., Zhang, L. et al. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 2009, 34(8): 1393-400.
218. Azcoitia, I., Moreno, A., Carrero, P. et al. Neuroprotective effects of soy phytoestrogens in the rat brain. Gynecol Endocrinol 2006, 22(2): 63-9.